Claudia Menzaghi

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 18

Top Topics

Genome Wide Association

Top Venues

Acta diabetologica

The Journal of clinical endocrinology and metabolism

Advanced biology

This page only lists publications with an associated author ORCID identifier.

Publications

Vincenzo Trischitta, Alessandra Antonucci, Jerzy Adamski, Cornelia Prehn, Claudia Menzaghi, Antonella Marucci, Rosa Di Paola
GALNT2 expression is associated with glucose control and serum metabolites in patients with type 2 diabetes. Acta diabetologica 61 (8) (2024)
Vincenzo Trischitta, Alessandra Antonucci, Jerzy Adamski, Cornelia Prehn, Claudia Menzaghi, Antonella Marucci, Rosa Di Paola
GALNT2 expression is associated with glucose control and serum metabolites in patients with type 2 diabetes. Acta diabetologica 61 (8) (2024)
Claudia Menzaghi, Antonella Marucci, Mario Mastroianno, Giulio Di Ciaccia, Maria Pia Armillotta, Cornelia Prehn, Lucia Salvemini, Davide Mangiacotti, Jerzy Adamski, Andrea Fontana, Salvatore De Cosmo, Olga Lamacchia, Massimiliano Copetti, Vincenzo Trischitta
Inflammation and prediction of death in type 2 diabetes. Evidence of an intertwined link with tryptophan metabolism. The Journal of clinical endocrinology and metabolism (2024)
Alessandra Antonucci, Claudia Menzaghi, Alessandro Roberto Dodesini, Mascia Albizzi, Angelo Acquafredda, Grazia Fini, Vincenzo Trischitta, Rosa Di Paola
Rare forms of monogenic diabetes in non-European individuals. First reports of CEL and RFX6 mutations from the Indian subcontinent. Acta diabetologica (2024)
Vincenzo Trischitta, Alessandra Antonucci, Jerzy Adamski, Cornelia Prehn, Claudia Menzaghi, Antonella Marucci, Rosa Di Paola
GALNT2 expression is associated with glucose control and serum metabolites in patients with type 2 diabetes. Acta diabetologica 61 (8) (2024)
Olga Lamacchia, Claudia Menzaghi, Massimiliano Copetti, Mario Mastroianno, Chiara Corsano, Cornelia Prehn, Jerzy Adamski, Andrea Fontana, Vincenzo Trischitta, Salvatore De Cosmo
GFR decline predicts total mortality and mediates the effect of tryptophan metabolism on death risk in type 2 diabetes. The Journal of clinical endocrinology and metabolism (2024)
Vincenzo Trischitta, Alessandra Antonucci, Claudia Menzaghi, Antonella Marucci, Rosa Di Paola
GALNT2 expression is associated with glucose control and serum metabolites in patients with type 2 diabetes. Acta diabetologica (2024)
Vincenzo Trischitta, Alessandra Antonucci, Jerzy Adamski, Cornelia Prehn, Claudia Menzaghi, Antonella Marucci, Rosa Di Paola
GALNT2 expression is associated with glucose control and serum metabolites in patients with type 2 diabetes. Acta diabetologica 61 (8) (2024)
Vincenzo Trischitta, Alessandra Antonucci, Jerzy Adamski, Cornelia Prehn, Claudia Menzaghi, Antonella Marucci, Rosa Di Paola
GALNT2 expression is associated with glucose control and serum metabolites in patients with type 2 diabetes. Acta diabetologica (2024)
Vincenzo Trischitta, Alessandra Antonucci, Jerzy Adamski, Cornelia Prehn, Claudia Menzaghi, Antonella Marucci, Rosa Di Paola
Correction: GALNT2 expression is associated with glucose control and serum metabolites in patients with type 2 diabetes. Acta diabetologica (2024)
Vincenzo Trischitta, Mario Mastroianno, Maria Giovanna Scarale, Cornelia Prehn, Lucia Salvemini, Andrea Fontana, Jerzy Adamski, Francesco Paolo Schena, Salvatore De Cosmo, Massimiliano Copetti, Claudia Menzaghi
Circulating metabolites improve the prediction of renal impairment in patients with type 2 diabetes. BMJ open diabetes research & care 11 (5) (2023)
Vincenzo Trischitta, Claudia Menzaghi, Massimiliano Copetti
Unveiling Novel Markers and Modeling Clinical Prediction of Treatment Effects Are Equally Important for Implementing Precision Therapeutics. Diabetes 72 (8) (2023)
Rosa Di Paola, Antonella Marucci, Davide Mangiacotti, Alessandra Antonucci, Andrea Fontana, Xuan Wang, Lu Qi, Claudia Menzaghi, Vincenzo Trischitta
Leveraging Genetics to Address the Role of GALNT2 on Atherogenic Dyslipidemia. Advanced biology (2023)
Maria Giovanna Scarale, Mario Mastroianno, Cornelia Prehn, Massimiliano Copetti, Lucia Salvemini, Jerzy Adamski, Salvatore De Cosmo, Vincenzo Trischitta, Claudia Menzaghi
Circulating Metabolites Associate With and Improve the Prediction of All-Cause Mortality in Type 2 Diabetes. Diabetes 71 (6) (2022)
Maria Giovanna Scarale, Alessandra Antonucci, Marina Cardellini, Massimiliano Copetti, Lucia Salvemini, Rossella Menghini, Tommaso Mazza, Viviana Casagrande, Gianluigi Ferrazza, Olga Lamacchia, Salvatore De Cosmo, Rosa Di Paola, Massimo Federici, Vincenzo Trischitta, Claudia Menzaghi
A Serum Resistin and Multicytokine Inflammatory Pathway Is Linked With and Helps Predict All-cause Death in Diabetes. The Journal of clinical endocrinology and metabolism 106 (11) (2021)
Maria Giovanna Scarale, Massimiliano Copetti, Monia Garofolo, Andrea Fontana, Lucia Salvemini, Salvatore De Cosmo, Olga Lamacchia, Giuseppe Penno, Vincenzo Trischitta, Claudia Menzaghi
The Synergic Association of hs-CRP and Serum Amyloid P Component in Predicting All-Cause Mortality in Patients With Type 2 Diabetes. Diabetes care 43 (5) (2020)
Claudia Menzaghi, Vincenzo Trischitta
The Adiponectin Paradox for All-Cause and Cardiovascular Mortality. Diabetes 67 (1) (2018)
Andrea Fontana, Lorena Ortega Moreno, Olga Lamacchia, Concetta De Bonis, Lucia Salvemini, Salvatore De Cosmo, Mauro Cignarelli, Massimiliano Copetti, Vincenzo Trischitta, Claudia Menzaghi
Serum resistin is causally related to mortality risk in patients with type 2 diabetes: preliminary evidences from genetic data. Scientific reports 7 (1) (2017)